The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-benzhydryl-4-[4-(1,2,4-triazol-1-yl)butyl]piperazine ID: ALA5192792
Chembl Id: CHEMBL5192792
PubChem CID: 14986611
Max Phase: Preclinical
Molecular Formula: C23H29N5
Molecular Weight: 375.52
Associated Items:
Names and Identifiers Canonical SMILES: c1ccc(C(c2ccccc2)N2CCN(CCCCn3cncn3)CC2)cc1
Standard InChI: InChI=1S/C23H29N5/c1-3-9-21(10-4-1)23(22-11-5-2-6-12-22)27-17-15-26(16-18-27)13-7-8-14-28-20-24-19-25-28/h1-6,9-12,19-20,23H,7-8,13-18H2
Standard InChI Key: SMRZRKQKIZLRQY-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 375.52Molecular Weight (Monoisotopic): 375.2423AlogP: 3.47#Rotatable Bonds: 8Polar Surface Area: 37.19Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 8.29CX LogP: 3.67CX LogD: 2.72Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.57Np Likeness Score: -1.53
References 1. Yamagiwa N, Komine M, Hanaoka F, Nobuta T, Yoshida K, Ito M, Matsuoka I.. (2022) Exploratory study of oxatomide derivatives with high P2X7 receptor inhibitory activity., 77 [PMID:36283612 ] [10.1016/j.bmcl.2022.129035 ]